Similar articles for PMID: 32859701

Year	Number of Results
2006	2
2011	1
2013	2
2014	3
2015	5
2016	11
2017	11
2018	9
2019	16
2020	23
2021	31
2022	29
2023	13
2024	1

1

First-in-Human Evaluation of ¹⁸F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A.

Naganawa M, Li S, Nabulsi N, Henry S, Zheng MQ, Pracitto R, Cai Z, Gao H, Kapinos M, Labaree D, Matuskey D, Huang Y, Carson RE. Naganawa M, et al. J Nucl Med. 2021 Apr;62(4):561-567. doi: 10.2967/jnumed.120.249144. Epub 2020 Aug 28. J Nucl Med. 2021. PMID: 32859701 Free PMC article. Clinical Trial.

2

Assessment of test-retest reproducibility of [¹⁸F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A.

Li S, Naganawa M, Pracitto R, Najafzadeh S, Holden D, Henry S, Matuskey D, Emery PR, Cai Z, Ropchan J, Nabulsi N, Carson RE, Huang Y. Li S, et al. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1327-1338. doi: 10.1007/s00259-020-05149-3. Epub 2021 Jan 8. Eur J Nucl Med Mol Imaging. 2021. PMID: 33416954

3

A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [¹⁸F]SDM-16.

Zheng C, Holden D, Zheng MQ, Pracitto R, Wilcox KC, Lindemann M, Felchner Z, Zhang L, Tong J, Fowles K, Finnema SJ, Nabulsi N, Carson RE, Huang Y, Cai Z. Zheng C, et al. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1482-1496. doi: 10.1007/s00259-021-05597-5. Epub 2021 Nov 11. Eur J Nucl Med Mol Imaging. 2022. PMID: 34761284 Free PMC article.

4

Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.

Nabulsi NB, Mercier J, Holden D, Carré S, Najafzadeh S, Vandergeten MC, Lin SF, Deo A, Price N, Wood M, Lara-Jaime T, Montel F, Laruelle M, Carson RE, Hannestad J, Huang Y. Nabulsi NB, et al. J Nucl Med. 2016 May;57(5):777-84. doi: 10.2967/jnumed.115.168179. Epub 2016 Feb 4. J Nucl Med. 2016. PMID: 26848175 Free article.

5

Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers.

Constantinescu CC, Tresse C, Zheng M, Gouasmat A, Carroll VM, Mistico L, Alagille D, Sandiego CM, Papin C, Marek K, Seibyl JP, Tamagnan GD, Barret O. Constantinescu CC, et al. Mol Imaging Biol. 2019 Jun;21(3):509-518. doi: 10.1007/s11307-018-1260-5. Mol Imaging Biol. 2019. PMID: 30084043

6

Validation, kinetic modeling, and test-retest reproducibility of [¹⁸F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in mice.

Bertoglio D, Zajicek F, Lombaerde S, Miranda A, Stroobants S, Wang Y, Dominguez C, Munoz-Sanjuan I, Bard J, Liu L, Verhaeghe J, Staelens S. Bertoglio D, et al. J Cereb Blood Flow Metab. 2022 Oct;42(10):1867-1878. doi: 10.1177/0271678X221101648. Epub 2022 May 14. J Cereb Blood Flow Metab. 2022. PMID: 35570828 Free PMC article.

7

Synthesis and in vivo evaluation of [¹⁸F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A).

Li S, Cai Z, Zhang W, Holden D, Lin SF, Finnema SJ, Shirali A, Ropchan J, Carre S, Mercier J, Carson RE, Nabulsi N, Huang Y. Li S, et al. Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1952-1965. doi: 10.1007/s00259-019-04357-w. Epub 2019 Jun 7. Eur J Nucl Med Mol Imaging. 2019. PMID: 31175396 Free PMC article.

8

Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [¹¹ C]UCB-J positron emission tomography study.

Finnema SJ, Toyonaga T, Detyniecki K, Chen MK, Dias M, Wang Q, Lin SF, Naganawa M, Gallezot JD, Lu Y, Nabulsi NB, Huang Y, Spencer DD, Carson RE. Finnema SJ, et al. Epilepsia. 2020 Oct;61(10):2183-2193. doi: 10.1111/epi.16653. Epub 2020 Sep 18. Epilepsia. 2020. PMID: 32944949

9

Simplified Quantification of ¹¹C-UCB-J PET Evaluated in a Large Human Cohort.

Naganawa M, Gallezot JD, Finnema SJ, Matuskey D, Mecca A, Nabulsi NB, Labaree D, Ropchan J, Malison RT, D'Souza DC, Esterlis I, Detyniecki K, van Dyck CH, Huang Y, Carson RE. Naganawa M, et al. J Nucl Med. 2021 Mar;62(3):418-421. doi: 10.2967/jnumed.120.243949. Epub 2020 Jul 9. J Nucl Med. 2021. PMID: 32646875 Free PMC article.

10

Cortical abnormalities of synaptic vesicle protein 2A in focal cortical dysplasia type II identified in vivo with ¹⁸F-SynVesT-1 positron emission tomography imaging.

Tang Y, Yu J, Zhou M, Li J, Long T, Li Y, Feng L, Chen D, Yang Z, Huang Y, Hu S. Tang Y, et al. Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3482-3491. doi: 10.1007/s00259-021-05665-w. Epub 2022 Jan 3. Eur J Nucl Med Mol Imaging. 2022. PMID: 34978594 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

120 results

Results by year